“Effect of Disease Modifying Agent on Oxidant and Antioxidant Status in Rheumatoid Arthritis”, Ann. Clin. Chem. & Lab. Med., vol. 3, no. 2, pp. 11–15, Aug. 2018, doi: 10.3126/acclm.v3i2.20738.